Free Trial

Armata Pharmaceuticals (ARMP) SEC Filings & 10K Form

Armata Pharmaceuticals logo
$1.95 -0.03 (-1.52%)
(As of 12/20/2024 04:32 PM ET)

Recent Armata Pharmaceuticals SEC Filings

DateFilerForm TypeView
12/19/2024
6:38 AM
Armata Pharmaceuticals, Inc. (Filer)
Armata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:15 PM
Armata Pharmaceuticals, Inc. (Filer)
Armata Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
6:07 AM
Armata Pharmaceuticals, Inc. (Filer)
Armata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
3:15 PM
Armata Pharmaceuticals, Inc. (Issuer)
Armata Pharmaceuticals (Issuer)
House David Duane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
3:15 PM
Armata Pharmaceuticals, Inc. (Filer)
Armata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
3:33 PM
Armata Pharmaceuticals, Inc. (Filer)
Armata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2024
6:50 AM
Armata Pharmaceuticals, Inc. (Filer)
Armata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
3:15 PM
Armata Pharmaceuticals, Inc. (Issuer)
Armata Pharmaceuticals (Issuer)
House David Duane (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
4:00 PM
Armata Pharmaceuticals, Inc. (Filer)
Armata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:20 PM
Armata Pharmaceuticals, Inc. (Filer)
Armata Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2024
3:15 PM
Armata Pharmaceuticals, Inc. (Filer)
Armata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2024
5:12 PM
Armata Pharmaceuticals, Inc. (Issuer)
Armata Pharmaceuticals (Issuer)
Kyme Pierre (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/07/2024
3:25 PM
Armata Pharmaceuticals, Inc. (Filer)
Armata Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/22/2024
7:00 AM
Armata Pharmaceuticals, Inc. (Filer)
Armata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2024
3:20 PM
Armata Pharmaceuticals, Inc. (Filer)
Armata Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/21/2024
3:15 PM
Armata Pharmaceuticals, Inc. (Filer)
Armata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
7:00 PM
Armata Pharmaceuticals, Inc. (Issuer)
Armata Pharmaceuticals (Issuer)
Birx Deborah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
7:00 PM
Armata Pharmaceuticals, Inc. (Issuer)
Armata Pharmaceuticals (Issuer)
Odysseas Kostas D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
7:01 PM
Armata Pharmaceuticals, Inc. (Issuer)
Armata Pharmaceuticals (Issuer)
Haimovitz Jules (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
7:02 PM
Armata Pharmaceuticals, Inc. (Issuer)
Armata Pharmaceuticals (Issuer)
Schlesinger Sarah J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
7:02 PM
Armata Pharmaceuticals, Inc. (Issuer)
Armata Pharmaceuticals (Issuer)
Rychlik Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
7:03 PM
Armata Pharmaceuticals, Inc. (Issuer)
Armata Pharmaceuticals (Issuer)
Peterson Todd C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
7:03 PM
Armata Pharmaceuticals, Inc. (Issuer)
Armata Pharmaceuticals (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
7:05 PM
Armata Pharmaceuticals, Inc. (Issuer)
Armata Pharmaceuticals (Issuer)
PATTI JOSEPH M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:35 PM
Armata Pharmaceuticals, Inc. (Subject)
Armata Pharmaceuticals (Subject)
Innoviva, Inc. (Filed by)
Form SC 13D/A
01/23/2024
3:17 PM
Armata Pharmaceuticals, Inc. (Filer)
Armata Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/26/2023
8:53 PM
Armata Pharmaceuticals, Inc. (Issuer)
Armata Pharmaceuticals (Issuer)
Odysseas Kostas D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
8:53 PM
Armata Pharmaceuticals, Inc. (Issuer)
Armata Pharmaceuticals (Issuer)
Birx Deborah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
8:53 PM
Armata Pharmaceuticals, Inc. (Issuer)
Armata Pharmaceuticals (Issuer)
Haimovitz Jules (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
8:54 PM
Armata Pharmaceuticals, Inc. (Issuer)
Armata Pharmaceuticals (Issuer)
Rychlik Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
8:54 PM
Armata Pharmaceuticals, Inc. (Issuer)
Armata Pharmaceuticals (Issuer)
PATTI JOSEPH M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
8:54 PM
Armata Pharmaceuticals, Inc. (Issuer)
Armata Pharmaceuticals (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
8:55 PM
Armata Pharmaceuticals, Inc. (Issuer)
Armata Pharmaceuticals (Issuer)
Peterson Todd C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
8:55 PM
Armata Pharmaceuticals, Inc. (Issuer)
Armata Pharmaceuticals (Issuer)
Schlesinger Sarah J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSEAMERICAN:ARMP) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners